CRT VALVE AORTIC: TAVR & PMVR: STATE OF THE FIELDS

Monday, February 27, 2023

8:00 AM – 11:30 AM ET

Moderator(s)

Maurice Buchbinder, MD, FSCAI

Medical Director
Foundation for Cardiovascular Medicine
San Diego, California, United States

No relationships to disclose
Kendra J. Grubb, MD

Surgical Director, Structural Heart and Valve Center
Emory University
Atlanta, Georgia, United States

Disclosure(s): 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)
TM

Thomas E. MacGillivray, MD

Physician Executive Director and Chair, Cardiac Surgery
MedStar Health, MedStar Washington Hospital Center
Washington, District of Columbia, United States

Disclosure(s): No financial relationships to disclose
Michael J. Reardon, MD

Professor and Allison Family Distinguished Chair of Cardiovascular Research
Houston Methodist DeBakey Heart & Vascular Center
Houston, Texas, United States

Disclosure(s): Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)

Disclosure(s):

Kendra J. Grubb, MD: 4C Medical Technologies, Inc.: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Abbot Vascular: Consultant/Advisory Board (Ongoing); Ancora Heart: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Bioventrix, Inc: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing); Boston Scientific: Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing); Edwards Lifesciences: Clinical Trial Investigator (Ongoing), Speakers' Bureau (Ongoing); JenaValve: Clinical Trial Investigator (Ongoing), Clinical Trial Support (Ongoing); Medtronic: Clinical Trial Investigator (Ongoing), Consultant/Advisory Board (Ongoing), Speakers' Bureau (Ongoing)

Thomas E. MacGillivray, MD: No financial relationships to disclose

Michael J. Reardon, MD: Abbott Medical: Consultant (Ongoing); Boston Scientific Corporation: Consultant (Ongoing); Medtronic: Consultant (Ongoing); W. L. Gore and Associates, Inc.: Consultant (Ongoing)